Healthcare

Establishment Labs Reports First Quarter 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

8 months ago

TruBridge and Multiview Announce Preferred Partnership Making Enhanced Financial Management Solutions Available to TruBridge Clients

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, and Multiview Financial Software (Multiview) announced a newly formed strategic…

8 months ago

Welter Healthcare Partners Earns Prestigious NCQA Credentials Verification Organization (CVO) Certification

Achieving this honor places Welter Healthcare Partners in an elite group of six companies that have achieved the coveted URAC…

8 months ago

Welter Healthcare Partners Earns Prestigious NCQA Credentials Verification Organization (CVO) Certification

Achieving this honor places Welter Healthcare Partners in an elite group of six companies that have achieved the coveted URAC…

8 months ago

Gilead’s FOCUS Program Helps Zero In on Early HIV Detection

NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at…

8 months ago

Gilead’s FOCUS Program Helps Zero In on Early HIV Detection

NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at…

8 months ago

Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services

SAN DIEGO, CA / ACCESSWIRE / May 9, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for…

8 months ago

Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services

SAN DIEGO, CA / ACCESSWIRE / May 9, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for…

8 months ago

Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)

Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adultsOvert Hepatic…

8 months ago

Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)

Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adultsOvert Hepatic…

8 months ago